Drug industry

Article Abstract:

Multinational corporations with good market capitalization, revenues, and earnings helped the drug industry achieve an earnings increase of 14.8% in 1996, and the first half of 1997 could see a better increase. Eli Lilly and ten other research-based multinationals saw their market capitalization grow 29% since May 1997 and 73.2% since Aug 1996. However, drug company stocks may have high valuations under market conditions and competition in 1997.

User Contributions:

Comment about this article or add new information about this topic:

Public Comment:  (50-4000 characters)

Name:

E-mail:

Type the code shown:

Show my email publicly:

Drug industry

Article Abstract:

The drug industry is doing well during 1997, with a 15% earnings increase per year for multinational firms. Investors with capital are fond of drug companies, especially large research firms. Those investors looking for drug equities should realize that many firms are appreciably high in terms of valuations. Caution is needed to select from these group, despite the high earnings growth.

User Contributions:

Comment about this article or add new information about this topic:

Public Comment:  (50-4000 characters)

Name:

E-mail:

Type the code shown:

Show my email publicly:

• Abstracts: Precious metals. inVentiv Health Inc
• Abstracts: Drug industry. Barr Pharm., Inc
• Abstracts: Drug industry. Bristol-Myers Sq